A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
RasCal Therapeutics, Inc.
RasCal Therapeutics, Inc.
West German Study Group
University of Eastern Finland
Institut du Cancer de Montpellier - Val d'Aurelle
MPN Research Foundation
AstraZeneca
Yale University
The University of Texas Health Science Center at San Antonio
Assistance Publique - Hôpitaux de Paris
Institute of Hematology & Blood Diseases Hospital, China
Sun Yat-sen University
Second Xiangya Hospital of Central South University
AtlasMedx, Incorporated
IRCCS San Raffaele